SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
We hope the outcome of this trial will enable the Company to procced with commercialization process for SCI-210 in Israel”
TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: …